Walgreen’s Vitamin Recall Issued Over Lack of Child-Proof Caps

Walgreen’s is recalling thousands of women’s multivitamin bottles, after recognizing the bottle cap design does not meet child-resistant standards, posing a potential health risk for young children if multiple tablets are ingested at once. 

The Walgreen’s Multivitamin Women 50+ tablets recall was announced by the U.S. Consumer Product Safety Commission (CPSC) on June 11, after the manufacturer learned the bottle caps are not child-resistant and senior friendly as required by the Poison Prevention Packaging Act.

The CPSC is urging consumers to place the vitamin bottles out of the reach of children immediately, due to the supplements containing iron, which can cause serious injury or death to young children if multiple tablets are ingested at once.

Ultra-Processed-Foods-Lawsuit-Lawyer
Ultra-Processed-Foods-Lawsuit-Lawyer

The recall involves “Well at Walgreens” brand name Multivitamin Women 50+ tablets containing UPC number 3-11917-17262-0 and lot numbers 000001 with expiration date September 2016, 000002 with expiration date December 2016, or 000003 with expiration date November 2016. The multivitamins were sold in white plastic bottles containing 200 tablets and has the wording “Well at Walgreens Multivitamin Women 50+” printed on the bottle’s white and silver label. A yellow label at the top of the bottle states “Value Size”.

The CPSC requested the recall due to the potential dangers the pill bottles pose to young children and the designs failure to be senior-friendly. The Poison Prevention Packaging Act set forth by the American Association of Poison Control Center mandates that pills bottles must be designed or constructed to be significantly difficult for children under five years of age to open within a reasonable time, and not difficult for normal adults, the elderly, or handicapped to use.

The multivitamins were manufactured in the U.S. under International Vitamin Corporation of Freehold, New Jersey where they were sold exclusively at Walgreens drug stores nationwide from January 2015 through March 2015 for about $16.

Customers are being asked to immediately place the multivitamin bottles out of the reach of children and contact Vitamin Corp. at 866-927-5470 or visit them at www.ivcinc.com and navigate to the Safety Recall link for information on how to obtain a free replacement child-resistant cap.

Walgreen’s has also announced a recall of Nice! Powdered Sugar Mini Donuts recall this week, due to a risk of mold on products sold exclusively at Walgreen’s stores.

The powdered donuts were sold nationwide in 11.5 ounce packages and can be identified by the WIC number 178206 and UPC number 4902264948. Both product identification numbers can be located on the product bar code.

Walgreen’s is asking customers to return the product to any Walgreens store for a full refund or contact the company’s customer service at 1-800-925-4733 for further questions.


0 Comments


Share Your Comments

This field is hidden when viewing the form
I authorize the above comments be posted on this page
Post Comment
Weekly Digest Opt-In

Want your comments reviewed by a lawyer?

To have an attorney review your comments and contact you about a potential case, provide your contact information below. This will not be published.

NOTE: Providing information for review by an attorney does not form an attorney-client relationship.

This field is for validation purposes and should be left unchanged.

MORE TOP STORIES

A West Virginia woman’s lawsuit over complications with a Cartiva implant has been scheduled to go before a jury in February 2026, involving claims that the big toe implant failed just weeks before the manufacturer issued a Cartiva recall.
A federal judge has rejected a motion to dismiss claims involving wrongful death and negligence raised in lawsuits over social media addiction brought by families throughout the U.S.
A group of eight lawyers have been recommended to serve in various leadership positions in the Biozorb litigation, taking actions that benefit all plaintiffs pursuing cases over injuries caused by the recalled breast tissue marker.